کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10896893 | 1083813 | 2005 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
WNLHSILASCUSBCCCervical intraepithelial neoplasia - neoplasia intraepithelial گردن رحمArginine - آرژنین Arg - ارگGenetic susceptibility - استعداد ژنتیکی یا آسیب پذیری ژنتیکی Malignant transformation - تحول بدخیمHPV testing - تست HPVDNA sequencing - توالی یابی DNA، تعیین توالی دیانایbase pair - جفت پایهCin - جینwithin normal limits - در حد عادیretinoblastoma - رتینوبلاستوما، تومور شبکیهconfidence interval - فاصله اطمینانMeta-analysis - فرا تحلیل Cervical neoplasia - نئوپلاسم گردنیPRO - نرم افزارodds ratio - نسبت شانس هاBiomarkers - نشانگر زیستی یا بیومارکرpolymerase chain reaction - واکنش زنجیره ای پلیمرازPCR - واکنش زنجیرهٔ پلیمرازHuman papillomavirus - ویروس پاپیلوم انسانیHPV - ویروس پایپلوم انسانیProline - پرولینGenetic polymorphism - پلیمورفیسم ژنتیکیProgression - پیشرفتp53 gene - ژن p53Case–control - کنترل مورد
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia](/preview/png/10896893.png)
چکیده انگلیسی
Background: The Arg/Arg genotype versus Arg/Pro or Pro/Pro at codon 72 of the p53 gene has been implicated in increasing susceptibility of the cervix to human papillomavirus (HPV) infection and thus altering cancer risk. However, research on this topic has been contentious, which prompted us to carry out a case-control study in the Montreal area. Methods: Cases were women with histologically-confirmed high-grade cervical intraepithelial neoplasia (HGCIN). Controls were women without a history of cervical abnormalities. From each woman, we obtained a cervical specimen for HPV testing and p53 genotyping, and a questionnaire was completed. DNA sequencing was used to minimize genotype misclassification. A subsample of specimens was also genotyped using the TaqMan assay. Results: There were 357 cases and 760 controls recruited between February 2001 and December 2003. The distribution of Arg/Arg, Arg/Pro and Pro/Pro was 55.2, 36.4 and 8.4%, respectively, among cases, and 52.1, 38.7 and 9.2%, among controls, corresponding to an odds ratio (OR) adjusted for ancestral origin of 1.16 (95% confidence interval (CI): 0.9-1.5) for Arg/Arg versus other genotypes. When restricted to high-risk HPV-positive women, the adjusted ORs were 1.40 (CI: 0.9-2.1) and 2.12 (CI: 1.1-4.2), for Arg/Arg versus other genotypes and versus Pro/Pro, respectively. The findings were comparable with analyses of genotype results that agreed between DNA sequencing and TaqMan. Conclusions: In this study, we attempted to minimize selection bias, population stratification and genotype misclassification. The results suggest that the role of the p53 codon 72 polymorphism on HGCIN is weak at best. Further research may reveal if the polymorphism has a stronger influence on the risk of invasive cervical cancer.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Cancer Detection and Prevention - Volume 29, Issue 4, 2005, Pages 307-316
Journal: Cancer Detection and Prevention - Volume 29, Issue 4, 2005, Pages 307-316
نویسندگان
Anita PhD, Anirban PhD, Eliane MD, Pierre MSc, Hélène MSc, Greg PhD, François MD, Eduardo L. PhD, Biomarkers of Cervical Cancer Risk (BCCR) Study Team Biomarkers of Cervical Cancer Risk (BCCR) Study Team,